TIGIT/PVR/NECTIN immune checkpoint axis expression across breast cancer subtypes.

被引：0
|
作者：
DuPree, Kelly J. [1 ]
Molinero, Luciana [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Defining the Immune Checkpoint Landscape in Human Colorectal Cancer Highlights the Relevance of the TIGIT/CD155 Axis for Optimizing Immunotherapy
    Ducoin, Kathleen
    Bilonda-Mutala, Linda
    Deleine, Cecile
    Oger, Romain
    Duchalais, Emilie
    Jouand, Nicolas
    Bossard, Celine
    Jarry, Anne
    Gervois-Segain, Nadine
    CANCERS, 2022, 14 (17)
  • [42] Tumor immune microenvironment drives prognostic relevance correlating with bladder cancer subtypes.
    Eckstein, Markus
    Pfannstiel, Carolin
    Chiappinelli, Katherine B.
    Sikic, Danijel
    Wach, Sven
    Wirtz, Ralph M.
    Wullweber, Adrian
    Taubert, Helge
    Breyer, Johannes
    Otto, Wolfgang
    Worst, Thomas
    Burger, Maximilian
    Wullich, Bernd
    Bolenz, Christian
    Fuhrich, Nicole
    Geppert, Carol
    Weyerer, Veronika
    Stoehr, Robert
    Bertz, Simone
    Keck, Bastian
    Erlmeier, Franziska
    Erben, Philipp
    Hartmann, Arndt
    Strissel, Pamela
    Strick, Reiner
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 32 - 32
  • [43] TIGIT, the Next Step Towards Successful Combination Immune Checkpoint Therapy in Cancer
    Ge, Zhouhong
    Peppelenbosch, Maikel P.
    Sprengers, Dave
    Kwekkeboom, Jaap
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [44] Expression and Clinical Significance of TIGIT in Primary Breast Cancer
    Tang, Limin
    Sha, Min
    Guo, Ting
    Lu, Huimin
    Qian, Jingyu
    Shao, Qixiang
    Ye, Jun
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 2405 - 2417
  • [45] PD-1 and TIGIT are major immune checkpoint receptors expressed in breast cancer-infiltrating T cells
    Kim, Jee Ye
    Kwon, Minsuk
    Lim, Sung Mook
    Kim, Joo Heung
    Park, Hyung Seok
    Park, Seho
    Kim, Seung Il
    Cho, Young Up
    Paik, Soonmyung
    Shin, Eui-Cheol
    CANCER RESEARCH, 2017, 77
  • [46] Variation in the immune cell infiltrate and expression of PD-L1 in sarcoma subtypes.
    Andrulis, Irene L.
    CLINICAL CANCER RESEARCH, 2018, 24 (02) : 25 - 25
  • [47] Heterogeneity in Nectin-4 expression across molecular subtypes of urothelial cancer mediates sensitivity to enfortumab vedotin.
    Chu, Carissa
    Sjostrom, Martin
    Egusa, Emily A.
    Gibb, Ewan
    Badura, Michelle L.
    Koshkin, Vadim S.
    Stohr, Bradley A.
    Meng, Maxwell
    Pruthi, Raj
    Friedlander, Terence W.
    Lotan, Yair
    Black, Peter C.
    Porten, Sima P.
    Feng, Felix Y.
    Chou, Jonathan
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [48] Clinical relevance of TNM staging system according to breast cancer (BC) subtypes.
    Park, Y.
    Lee, S.
    Kong, J.
    Cho, E.
    Choi, Y.
    Lee, J.
    Nam, S.
    Yang, J.
    Ahn, J.
    Im, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [49] FDG-PET texture analysis in breast cancer according to molecular subtypes.
    Boughdad, Sarah
    Nioche, Christophe
    Orlhac, Fanny
    Champion, Laurence
    Alberini, Jean Louis
    Buvat, Irene
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [50] ADAR-mediated RNA editing regulates PVR immune checkpoint in colorectal cancer
    Qian, Cheng-Jia
    He, Yu -Shan
    Guo, Tao
    Tao, Ji
    Wei, Zhi-Yuan
    Zhang, Jia-Li
    Bao, Chuanqing
    Chen, Jian-Huan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 695
12345